Delivery Order SPE2DB22D3016-SPE2DB25FAQW1

Award Date 3/10/25
Potential Completion Date 3/31/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,917.64 and is a delivery order that runs through March 31, 2025. The contract is for the procurement of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical product. This contract award is not associated with a set-aside designation, indicating open competition....
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is a Firm Fixed Price Delivery Order for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $4,753.36 and a completion date of December 10, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $3,565.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical product, with a period of performance ending on December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation (AmerisourceBergen) for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has a firm fixed price of $4,753.36 and a period of performance through September 19, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded this order as part of its Indefinite Delivery Contract (IDC) with...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, with a ceiling value of $3,688.23 and a completion date of February 19, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, and has a ceiling value of $2,458.82. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, which is valued at $999,999,999 and runs through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,458.82, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,688.23 delivery order contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4567489920 ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has a firm fixed-price delivery order structure with a ceiling value of $3,688.23 and a period of performance running through March 27, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAQW1
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical product. The contract has a ceiling value of $7,376.46 and runs through March 31, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 6/9/25, 9:42 AM